ARTICLE | Company News
GenVec, Novartis deal
February 6, 2012 8:00 AM UTC
GenVec and Novartis extended by one year through January 2013 a 2010 deal granting the pharma exclusive, worldwide rights to GenVec's preclinical hearing loss and balance disorders program. Novartis i...